Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18490,144,1.31 [0.91-1.89],0.1460544500860821
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19442,201,1.19 [0.85-1.66],0.309989554522417
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19215,1407,1.15 [1.01-1.31],0.0311597909578012
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Candidiasis,19456,437,1.22 [0.98-1.52],0.0718294581382408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18821,3439,1.14 [1.05-1.24],0.0017119967491305
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18799,3481,1.23 [1.13-1.33],4.882363805815426e-07
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19207,1165,1.17 [1.02-1.35],0.021263977906367
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19365,105,1.25 [0.80-1.94],0.326182471331483
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17171,1019,1.35 [1.18-1.55],1.747919038015955e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16565,1242,1.28 [1.12-1.46],0.0002106964380244
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16209,264,1.06 [0.76-1.48],0.7351100755990896
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12707,2209,1.15 [1.04-1.28],0.0062127074709805
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16152,392,1.11 [0.85-1.45],0.4414542330289227
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19420,1378,1.16 [1.02-1.32],0.022573253681186
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,19522,503,1.18 [0.96-1.45],0.1256991373032593
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18798,990,1.26 [1.09-1.45],0.0015223367139608
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19467,1121,1.32 [1.16-1.50],2.049187510539017e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18243,201,1.20 [0.86-1.67],0.2833650288938106
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19571,51,1.39 [0.79-2.45],0.2567114242744714
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19330,984,1.34 [1.18-1.53],1.5043729042236048e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19325,65,1.24 [0.71-2.16],0.4422215786269433
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19519,106,0.82 [0.45-1.51],0.528567763689896
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19506,93,0.60 [0.28-1.27],0.1811188566439328
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18196,388,0.96 [0.72-1.28],0.7928447495172625
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18059,251,0.96 [0.66-1.39],0.8326279059468703
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18145,103,0.97 [0.55-1.70],0.9127043462621623
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19558,45,1.53 [0.88-2.66],0.1328122453657877
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19510,152,1.08 [0.72-1.63],0.6959532909339979
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral warts,19409,51,0.62 [0.23-1.65],0.3414015470980141
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19429,71,1.03 [0.54-1.95],0.9301019192595834
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,19327,221,0.90 [0.60-1.34],0.5895859194123709
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19499,35,1.11 [0.49-2.53],0.8042409181842514
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19484,40,0.39 [0.11-1.42],0.1533625746892238
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9250,70,1.35 [0.82-2.22],0.2361984541247411
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19184,1419,0.85 [0.72-1.00],0.044422525730405
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of meninges,19558,57,1.82 [1.33-2.49],0.0001742477061685
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19493,70,1.56 [1.06-2.30],0.0231745099044884
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19548,101,0.92 [0.51-1.66],0.7904449905390087
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of ovary,10269,63,0.98 [0.50-1.93],0.9616814646858723
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19538,385,0.85 [0.63-1.17],0.3208965760365297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Caecum,19549,326,0.86 [0.61-1.20],0.3711493615860093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19449,75,0.71 [0.32-1.54],0.3822570990582646
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Descending colon,19536,219,0.92 [0.62-1.37],0.6761574124005219
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,19495,346,0.74 [0.52-1.05],0.0943611318722749
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19438,589,1.02 [0.82-1.27],0.8797945707850997
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19529,447,0.83 [0.62-1.11],0.2099249303789918
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Carcinoma in situ of breast,7735,44,1.20 [0.65-2.21],0.5635592314769988
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7766,53,1.35 [0.82-2.23],0.2405515978103143
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14009,59,0.75 [0.32-1.75],0.5028077842158787
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14034,84,0.99 [0.55-1.78],0.9719357074372302
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19522,106,0.99 [0.59-1.66],0.9737911051271254
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma, any site",19523,103,0.92 [0.52-1.60],0.7578636497635483
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Leiomyoma of uterus,10039,145,1.29 [0.94-1.78],0.1179219811557975
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Lung cancer and mesothelioma,12483,422,1.16 [0.85-1.60],0.3466804338188047
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Lymphoid leukaemia,14010,60,0.85 [0.39-1.86],0.680392152919495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14135,185,1.20 [0.86-1.67],0.2747509566077085
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14204,254,1.27 [0.95-1.68],0.1019734739188743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7849,98,1.16 [0.73-1.87],0.5289787063043889
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14046,96,0.98 [0.55-1.75],0.9439636157068176
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14071,121,1.15 [0.72-1.83],0.555656244443439
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14061,111,1.29 [0.84-1.97],0.2490672153251756
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7830,79,0.99 [0.55-1.79],0.9727789427551656
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14056,106,0.85 [0.47-1.56],0.6058651025212679
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7008,809,1.10 [0.92-1.33],0.2907564741602377
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14063,113,0.91 [0.52-1.58],0.7322507893263246
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14033,83,1.84 [1.33-2.54],0.0002246956480644
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14069,119,1.10 [0.69-1.75],0.6888576762476668
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi,19446,160,1.02 [0.67-1.53],0.9398164462221392
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi of trunk,19547,67,0.57 [0.23-1.39],0.2193823301847321
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanoma in situ,13991,93,0.86 [0.46-1.58],0.6201227075512421
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14053,103,1.11 [0.68-1.80],0.6822542904663358
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14121,171,1.18 [0.83-1.68],0.3678514394283605
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14245,295,1.11 [0.82-1.50],0.5031132661944484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14062,112,1.17 [0.76-1.82],0.4748437821619565
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Other benign neoplasms of skin,19431,145,0.75 [0.44-1.28],0.2980395499323546
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15187,1237,1.10 [0.96-1.26],0.1872239483630182
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15252,1302,1.11 [0.97-1.27],0.1340824113492968
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19314,321,1.13 [0.86-1.47],0.3927733492448164
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17681,106,1.37 [0.93-2.02],0.1132340273793104
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19054,61,1.69 [1.18-2.41],0.0038444807951359
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,18962,2876,1.11 [1.01-1.21],0.0318877244638255
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18171,59,1.15 [0.61-2.17],0.6571694002060484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19177,56,1.65 [1.11-2.45],0.0125154971632038
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19172,1597,1.12 [0.99-1.27],0.0618794286739329
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19170,1595,1.12 [0.99-1.27],0.0611604208721943
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17670,95,1.14 [0.69-1.87],0.6025486002110987
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19271,1159,1.12 [0.97-1.29],0.1368283994005616
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19224,103,0.88 [0.49-1.58],0.6729204608172068
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19052,59,1.02 [0.50-2.09],0.9478909991503291
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19061,68,0.73 [0.33-1.63],0.4404934248653445
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19412,291,1.28 [0.99-1.66],0.0585713002610388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19469,31,1.09 [0.45-2.65],0.8560809526573678
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19359,238,1.25 [0.94-1.68],0.1278812237917454
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18223,111,1.36 [0.93-1.97],0.1095776958611604
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13245,330,1.13 [0.84-1.52],0.4314797355819031
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18305,87,1.27 [0.60-2.69],0.5364145301054973
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18309,91,1.04 [0.57-1.90],0.8880336822832863
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12975,60,1.65 [1.05-2.57],0.0284957328178515
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18220,44,1.61 [0.96-2.69],0.0702407545646735
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17598,261,0.98 [0.69-1.38],0.8969518732192883
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18939,750,1.10 [0.92-1.33],0.2939780347166756
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18598,409,0.91 [0.69-1.20],0.5120960330682597
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18330,141,1.28 [0.90-1.82],0.1692577410172085
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19348,1172,1.12 [0.97-1.29],0.1373003563618628
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16570,1142,1.12 [0.97-1.30],0.1184139143861185
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",12986,71,1.19 [0.66-2.14],0.5559433754464278
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17670,84,0.59 [0.26-1.32],0.196667629665465
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13218,303,1.33 [1.04-1.71],0.0229787080036866
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12963,48,1.41 [0.79-2.50],0.2477924903564689
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16730,3815,1.01 [0.93-1.11],0.7718304569882993
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13143,228,1.26 [0.93-1.71],0.1397605769313817
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13508,593,1.25 [1.03-1.51],0.0207593561752653
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19523,310,1.34 [1.06-1.69],0.015590527772104
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19337,124,1.57 [1.16-2.11],0.0033003461067479
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13035,120,1.10 [0.68-1.77],0.6949905643768404
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",12982,67,0.94 [0.46-1.92],0.8614149701619845
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19037,1451,1.23 [1.09-1.38],0.0005037782338327
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13216,301,1.43 [1.11-1.84],0.0064143310599559
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13236,321,1.36 [1.06-1.75],0.0160367950485567
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13637,722,0.94 [0.75-1.17],0.5670767206448925
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13040,125,1.07 [0.65-1.75],0.7967043247858505
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19331,118,1.34 [0.91-1.97],0.1384594327578618
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13656,741,1.20 [1.01-1.42],0.0368966576787259
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13451,536,1.26 [1.04-1.53],0.017910572160519
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17395,58,0.96 [0.46-2.02],0.9154134599335444
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18273,5358,1.10 [1.02-1.18],0.0104424578350022
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17635,49,1.14 [0.57-2.29],0.7051021492870094
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17632,46,1.48 [0.88-2.47],0.1370052531113241
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19423,1548,1.04 [0.90-1.20],0.6174935032468556
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19422,1547,1.04 [0.90-1.20],0.6079366131394552
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17639,53,0.77 [0.31-1.90],0.5718891589864175
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19268,950,1.04 [0.88-1.23],0.6260668545742478
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14738,1823,1.26 [1.14-1.41],1.9911345996645783e-05
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19560,241,1.40 [1.06-1.85],0.019545666154768
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18284,95,0.79 [0.41-1.52],0.4824683847923604
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18419,101,0.82 [0.44-1.51],0.5204803010717799
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18461,143,0.91 [0.56-1.48],0.7039962164204887
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13075,160,1.49 [1.15-1.91],0.00220318385595
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17242,156,0.71 [0.41-1.24],0.2288281394153813
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2078,82,1.01 [0.54-1.89],0.96510223532835
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2214,250,1.15 [0.82-1.60],0.4141242843211751
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17153,67,1.57 [0.96-2.57],0.0746119284620591
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2046,51,1.46 [0.78-2.73],0.2323423227650236
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18885,1799,1.08 [0.95-1.23],0.2440950409887414
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18677,488,1.12 [0.90-1.40],0.2961180634515554
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17708,371,1.06 [0.81-1.39],0.6792488930511932
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13805,890,1.17 [0.99-1.38],0.0671701336692412
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19459,262,1.15 [0.86-1.55],0.3465908441698526
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18331,229,1.13 [0.80-1.59],0.4749216430355757
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,16968,1276,1.06 [0.92-1.23],0.4017010147306252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18417,315,1.01 [0.74-1.39],0.9302115224994912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18168,66,1.08 [0.57-2.06],0.8082522627029964
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18335,233,1.33 [1.00-1.77],0.04731055172804
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10007,2347,1.09 [0.98-1.22],0.107550550872479
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,AV-block,14987,552,1.04 [0.82-1.31],0.770312017369261
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19503,461,1.20 [0.97-1.49],0.1004811927407102
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiac arrest,7880,220,1.37 [1.01-1.88],0.0449822174813904
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14606,171,1.16 [0.79-1.69],0.4555951456051553
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14522,87,0.74 [0.36-1.53],0.4210331355515677
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19566,61,1.16 [0.61-2.19],0.6503549881417288
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,15703,1268,1.14 [0.99-1.31],0.0783342331404513
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17962,2292,1.09 [0.97-1.21],0.1360924170556236
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15857,7520,1.06 [1.00-1.13],0.0459073524313455
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18276,286,1.12 [0.84-1.50],0.4445885305592622
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Endocarditis,14511,76,1.07 [0.59-1.94],0.8240150520913581
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19330,1363,1.27 [1.12-1.44],0.0002427697595231
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,16890,6652,1.03 [0.97-1.10],0.3096199686716882
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16895,6657,1.03 [0.97-1.10],0.3189440161580537
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19431,81,1.08 [0.60-1.95],0.801493228547911
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10476,238,1.42 [1.09-1.85],0.0103327713215188
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10361,123,1.75 [1.35-2.28],2.762249322645687e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,19425,1309,1.16 [1.01-1.33],0.0301151831239033
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18525,121,1.23 [0.83-1.83],0.3076352836939506
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18106,2414,1.06 [0.95-1.18],0.2974115874864836
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19158,648,1.18 [0.98-1.43],0.0758696977063454
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14854,419,1.36 [1.11-1.67],0.0035419240031651
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19018,883,1.18 [1.01-1.39],0.0416547581959147
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16449,757,1.16 [0.97-1.38],0.0938543286146635
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19460,159,1.33 [0.95-1.85],0.0980131531897884
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19532,334,0.84 [0.60-1.18],0.3149875408640596
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Oesophageal varices,18047,57,1.23 [0.65-2.33],0.5149235121103228
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other aneurysm,18188,86,0.85 [0.44-1.64],0.6202038079888392
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,14935,500,1.13 [0.90-1.41],0.2792624932452553
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18211,109,1.36 [0.90-2.04],0.1427559130333864
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18372,270,1.18 [0.88-1.57],0.2714431780223805
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14624,189,1.00 [0.66-1.50],0.98500015056769
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other disorders of veins,18078,88,1.06 [0.58-1.92],0.8539117202706672
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18027,37,1.50 [0.80-2.79],0.2071431649426805
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17900,73,0.98 [0.51-1.88],0.944614791034353
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18129,139,0.95 [0.57-1.59],0.8457409258446791
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15613,1178,1.25 [1.09-1.44],0.0013095053275514
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18164,48,0.90 [0.37-2.17],0.813708780938583
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18706,604,1.16 [0.95-1.41],0.1363343322201925
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18924,457,1.33 [1.09-1.63],0.0054711471328633
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18620,793,1.15 [0.97-1.37],0.1117674747775387
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8009,349,1.12 [0.85-1.48],0.4203440456974319
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18556,484,1.10 [0.87-1.40],0.4253078651757276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18347,357,1.16 [0.90-1.50],0.2639354169814123
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,18963,496,1.14 [0.92-1.43],0.2294745798323163
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19485,790,1.09 [0.91-1.30],0.365626040838951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14862,427,1.11 [0.86-1.43],0.4301943828909977
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18919,452,1.34 [1.10-1.64],0.0043491265378727
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18043,216,1.49 [1.16-1.92],0.0018250223566339
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19142,738,1.17 [0.98-1.39],0.0863091123945867
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19131,771,1.18 [0.99-1.40],0.0596379113181309
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18501,51,0.96 [0.45-2.07],0.9173034540451244
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18182,80,0.87 [0.45-1.69],0.683959787247902
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18767,257,1.00 [0.71-1.40],0.9988207672329156
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18412,277,1.29 [0.99-1.68],0.0626423232419115
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Varicose veins,18418,428,1.12 [0.89-1.43],0.3313542133445502
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18117,98,0.74 [0.38-1.45],0.3802284621230285
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19334,785,1.14 [0.96-1.36],0.1444491156085124
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19501,283,1.00 [0.72-1.40],0.9886645666468336
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16818,1163,1.02 [0.87-1.19],0.8070016074976348
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,19136,3481,1.08 [0.99-1.18],0.0731326773407284
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19477,334,0.99 [0.73-1.35],0.9729715563374792
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16847,1192,1.13 [0.98-1.30],0.0928467323223109
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15718,63,1.27 [0.73-2.21],0.3996371068141814
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Smoking dependency,19149,981,1.03 [0.84-1.26],0.7849522633168187
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16871,1216,1.09 [0.91-1.30],0.3488717312917808
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Vascular dementia,18872,195,0.94 [0.62-1.41],0.7474708298773269
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Alzheimer disease,19568,503,0.94 [0.73-1.20],0.6090701931608574
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",12214,98,0.68 [0.34-1.36],0.272896635190475
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Bell's palsy,18040,70,1.37 [0.86-2.20],0.1888426889206795
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18387,417,0.90 [0.68-1.21],0.4926701320003295
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral cysts,19204,205,1.21 [0.88-1.66],0.2322804439857421
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19507,326,1.17 [0.89-1.53],0.2671361202683407
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18877,69,0.98 [0.51-1.87],0.942659517503609
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19552,59,1.26 [0.70-2.25],0.4405415102112509
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19068,69,1.44 [0.93-2.25],0.1054097436559116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Epilepsy,18341,246,1.02 [0.74-1.43],0.8867462236697053
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19190,1095,1.04 [0.88-1.22],0.6616543479897461
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19519,536,0.99 [0.78-1.24],0.9044943201262992
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19011,2819,1.09 [0.99-1.20],0.0815403884989979
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Generalized epilepsy,19260,44,1.05 [0.48-2.28],0.90320374572723
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hemiplegia,19447,266,1.13 [0.83-1.54],0.4350270875766392
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hydrocephalus,19058,59,0.83 [0.38-1.85],0.6536370234461271
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19556,58,1.09 [0.58-2.07],0.7856545456157411
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18033,63,0.76 [0.34-1.70],0.505196769783915
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18030,60,1.20 [0.64-2.24],0.57691326240811
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Memory loss,18657,127,0.62 [0.33-1.16],0.1352727729615187
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Migraine,18323,228,1.14 [0.84-1.55],0.4136556646191622
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19527,208,1.10 [0.79-1.53],0.5826949785531375
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Motor neuron disease,12295,158,0.81 [0.50-1.32],0.4077062433982704
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19462,49,0.70 [0.26-1.83],0.4643553807296255
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",18989,1019,1.08 [0.92-1.26],0.3637713726614313
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,18342,3477,1.07 [0.98-1.17],0.1171834245472523
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19045,237,0.81 [0.54-1.21],0.3041645202489598
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18306,336,0.88 [0.63-1.21],0.4283006149026046
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19502,282,1.25 [0.95-1.63],0.1113376313991222
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14855,797,0.96 [0.79-1.17],0.68637767930756
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19068,69,1.27 [0.74-2.16],0.3881208080323057
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19131,132,1.00 [0.62-1.62],0.9916481152024884
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19163,180,0.96 [0.64-1.44],0.8413292405331693
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18047,77,1.33 [0.83-2.14],0.231874527089905
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other headache syndromes,18138,43,0.84 [0.33-2.13],0.7216285091833174
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,19476,477,1.19 [0.96-1.47],0.1104852232873327
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,18513,418,1.03 [0.78-1.35],0.8499117471651783
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Parkinson's disease,19537,337,1.00 [0.75-1.34],0.9865816432462052
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19039,40,1.12 [0.53-2.34],0.7661038008183134
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Restless leg syndrome,19567,78,1.09 [0.62-1.90],0.7751028036991794
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,19384,358,1.05 [0.79-1.41],0.7291760055687055
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19270,50,1.09 [0.55-2.16],0.8108917477106409
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19556,179,0.76 [0.47-1.22],0.253783193305093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18029,59,1.45 [0.91-2.32],0.1187598532973556
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19568,507,0.94 [0.73-1.20],0.6168075843922981
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18816,189,0.94 [0.62-1.42],0.769052181616986
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19034,125,1.36 [0.97-1.92],0.0765880356062198
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19212,478,0.89 [0.68-1.16],0.38933534902025
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19366,222,1.11 [0.77-1.59],0.5762825010483201
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18537,58,1.12 [0.60-2.10],0.7278775422381628
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18510,31,1.26 [0.59-2.71],0.551351130525717
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19465,62,1.81 [1.28-2.57],0.0008865081364114
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19308,192,0.86 [0.56-1.33],0.5064585211206902
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2050,54,1.48 [0.82-2.69],0.1954886267430576
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2524,94,1.12 [0.64-1.93],0.6954681786182815
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19000,91,0.83 [0.44-1.57],0.5579279799881602
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19338,1188,1.01 [0.87-1.18],0.8676200500070035
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19217,738,1.24 [1.06-1.47],0.0085710688474687
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18734,255,1.32 [1.03-1.71],0.0311480821899005
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19517,783,1.03 [0.86-1.24],0.7294855642105236
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19562,66,1.19 [0.67-2.11],0.5540086489627984
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19468,734,1.02 [0.84-1.24],0.8048654990124622
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19534,418,0.89 [0.67-1.19],0.4379255008677026
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19470,187,0.96 [0.64-1.44],0.8419935704209591
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18568,89,1.63 [1.15-2.31],0.0064147309611967
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18565,86,1.23 [0.76-2.01],0.4007378000367746
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18544,65,0.77 [0.36-1.68],0.519256882805607
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19456,836,0.91 [0.75-1.11],0.3735747295334403
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18854,234,0.88 [0.60-1.29],0.5286786346356303
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18788,54,1.04 [0.52-2.10],0.909609104378318
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19218,102,0.54 [0.26-1.13],0.1046264469874816
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19444,328,0.99 [0.73-1.34],0.9640691724698852
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18916,182,1.28 [0.94-1.74],0.1195349000266211
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19397,114,0.90 [0.53-1.53],0.6934753479845258
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19161,541,0.92 [0.72-1.18],0.5148570355916258
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19046,137,1.07 [0.69-1.65],0.7681050569493321
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17519,2720,1.08 [0.98-1.19],0.1422524764110204
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19408,292,0.97 [0.70-1.34],0.8417964326819916
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19552,161,1.10 [0.74-1.63],0.6425714706209592
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18936,457,1.25 [1.01-1.53],0.0379903191895563
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19191,75,0.48 [0.20-1.18],0.1112428012068913
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19555,59,1.10 [0.57-2.11],0.7785501655618297
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18583,104,1.02 [0.60-1.71],0.9458671271784664
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18628,149,1.06 [0.70-1.62],0.7709287729645091
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18291,141,1.09 [0.72-1.65],0.6954646643191271
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18777,43,0.91 [0.38-2.19],0.8404805371487015
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18214,64,1.21 [0.71-2.08],0.4861237533313307
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18717,97,0.53 [0.25-1.12],0.0985307650082503
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18862,242,0.88 [0.60-1.28],0.4914446498770297
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18609,130,1.14 [0.75-1.74],0.5469849673299207
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18230,80,0.89 [0.47-1.68],0.7132068869617683
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18253,103,1.01 [0.60-1.71],0.966306310550568
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17069,2270,1.08 [0.97-1.20],0.1701076496077008
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18558,79,1.55 [1.07-2.26],0.0207008193669881
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19331,422,1.08 [0.85-1.38],0.5277923343222837
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,18976,67,0.87 [0.41-1.84],0.7177531064652583
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19069,160,1.04 [0.69-1.58],0.836605614211119
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19372,92,1.51 [1.06-2.16],0.0235188267006264
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19531,120,1.42 [0.99-2.02],0.0535805581014293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19456,96,1.33 [0.87-2.02],0.1839989924877066
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19336,56,0.71 [0.30-1.71],0.4503815849718388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,19341,61,0.88 [0.42-1.88],0.7493402439933641
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19473,997,1.18 [1.02-1.37],0.0305233074667764
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19234,758,1.19 [1.00-1.41],0.044868901852517
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18599,123,0.84 [0.48-1.48],0.5535421932060887
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18549,73,1.04 [0.56-1.92],0.9128319133946686
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute pharyngitis,19403,53,1.08 [0.54-2.14],0.8329844983746021
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19500,150,0.94 [0.59-1.50],0.8086603795722815
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19400,50,0.97 [0.45-2.12],0.9456266486264188
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,All influenza,17379,121,1.26 [0.84-1.88],0.2687788762417369
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17376,118,1.29 [0.87-1.92],0.2109469758820021
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12145,84,0.90 [0.48-1.68],0.7493473264726112
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Allergic rhinitis,19488,200,1.41 [1.08-1.83],0.0116630558915995
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13217,1475,1.04 [0.91-1.20],0.555324983251728
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13519,1458,1.04 [0.90-1.19],0.596883160625922
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19136,148,1.33 [0.94-1.88],0.1104459035199341
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17342,84,1.15 [0.67-1.99],0.6100032227534242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Bronchiectasis,16377,433,1.26 [1.02-1.55],0.0307979438486696
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16006,62,1.47 [0.94-2.31],0.0907587913908474
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18615,2671,1.11 [1.00-1.22],0.0453774514379467
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18530,63,1.23 [0.71-2.15],0.4592770064147304
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,18576,109,0.70 [0.37-1.32],0.2694209992016516
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19322,1357,1.15 [1.01-1.33],0.0404378148941921
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,18539,72,0.84 [0.41-1.72],0.6286344738601719
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17746,5089,1.09 [1.02-1.17],0.0171533978245035
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18765,298,1.15 [0.87-1.52],0.3358244087917388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Early onset COPD,18066,101,1.41 [0.93-2.13],0.1077539345613804
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Emphysema,16315,371,1.22 [0.95-1.58],0.1243444888698084
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18455,394,1.27 [1.01-1.59],0.0401794329246282
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19348,2090,1.23 [1.11-1.36],4.746678115962063e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,18490,429,1.28 [1.03-1.59],0.0255267144768564
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Later onset COPD,19111,1256,1.13 [0.98-1.31],0.095578452419451
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19552,385,1.11 [0.86-1.44],0.4098657275558631
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Nasal polyp,18552,85,0.60 [0.28-1.29],0.1883379008429582
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19328,1050,1.09 [0.93-1.27],0.3049095585541166
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,19327,2228,1.22 [1.10-1.34],0.00011329775673
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19109,642,1.12 [0.93-1.36],0.2365538514552409
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other pleural conditions,17150,51,1.50 [0.90-2.50],0.1210623757559939
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19452,505,1.22 [1.00-1.50],0.054239748906071
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19456,1438,1.19 [1.05-1.35],0.0067442320968632
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,18203,1104,1.24 [1.08-1.43],0.0017871901272578
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural plaque,17320,221,1.34 [0.99-1.80],0.054399208014094
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19114,1856,1.23 [1.11-1.37],0.0001283466153429
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19453,286,1.14 [0.85-1.52],0.3925786614851911
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pneumothorax,17248,149,0.82 [0.49-1.38],0.4582322077957425
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pollen allergy,19560,168,1.50 [1.15-1.95],0.0024137702408437
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pulmonary oedema,19021,74,0.93 [0.46-1.85],0.8253685500021009
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12118,57,1.35 [0.54-3.41],0.5215813115392872
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19315,1037,1.09 [0.93-1.28],0.2966112936351466
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18668,201,1.40 [1.08-1.83],0.0118981883736945
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Viral pneumonia,17501,243,1.16 [0.84-1.61],0.3773033395245724
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19147,195,0.99 [0.65-1.50],0.948195668969712
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6314,104,1.43 [0.93-2.22],0.1050587707701022
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12510,51,1.50 [0.92-2.44],0.1056976913146636
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,19468,108,1.29 [0.87-1.92],0.2053924365045146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute gastritis,13688,85,1.63 [1.14-2.32],0.007044623798904
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,17871,164,1.15 [0.79-1.68],0.4630432661861526
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute peritonitis,19167,90,1.40 [0.93-2.10],0.1081450420048513
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18747,47,1.32 [0.68-2.58],0.4142170707964101
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Barrett oesophagus,14023,420,1.17 [0.93-1.47],0.1850256252696654
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17831,124,1.10 [0.69-1.76],0.6814073485633251
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19224,124,1.08 [0.68-1.73],0.7350114144618956
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholecystitis,17887,180,1.03 [0.69-1.54],0.8847979641722991
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,18578,871,1.10 [0.93-1.31],0.2728114145335156
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,13886,283,1.12 [0.84-1.51],0.4398609860481572
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17749,42,1.08 [0.50-2.36],0.8430781644542613
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19455,105,1.25 [0.79-1.99],0.3384015846694875
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,18118,106,1.46 [1.07-2.01],0.0181612226076862
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Collagenous colitis,18098,85,1.09 [0.65-1.84],0.7461096311637063
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19471,138,1.13 [0.75-1.72],0.5549271138467043
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Constipation,19331,1737,1.11 [0.98-1.25],0.1014344659553815
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn disease,18077,64,1.01 [0.53-1.96],0.9652395427797856
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19275,50,0.97 [0.45-2.11],0.9364979435146544
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18070,57,0.88 [0.40-1.92],0.7500691426062909
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Dental caries,19046,157,0.79 [0.47-1.31],0.3589988108808354
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16937,2144,1.00 [0.89-1.13],0.9613863954563358
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,19494,134,1.25 [0.86-1.81],0.2366671465680364
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of liver,19470,770,1.09 [0.90-1.31],0.3710590794200913
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17439,3836,1.03 [0.95-1.12],0.4635624553939702
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19279,390,0.85 [0.62-1.15],0.292076617403269
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19494,417,1.11 [0.87-1.41],0.4099085595981835
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,18964,75,0.91 [0.47-1.77],0.7894489011023269
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18862,47,1.59 [1.03-2.47],0.0377057009574244
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19295,1283,1.01 [0.87-1.18],0.847729565083575
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of tongue,18874,80,0.95 [0.51-1.77],0.8772726210870263
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18978,1271,1.12 [0.97-1.28],0.1213066222854947
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15640,3181,1.00 [0.91-1.10],0.9782871800296647
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,13798,195,1.14 [0.79-1.64],0.4805576941132832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19480,155,1.10 [0.74-1.65],0.6376333271130951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19539,20,0.89 [0.25-3.15],0.8616689408093712
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18823,123,1.02 [0.62-1.70],0.9330645415937966
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12551,92,1.07 [0.63-1.81],0.8113729989380146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,14073,470,0.98 [0.77-1.26],0.90342721322111
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,13964,361,1.11 [0.84-1.45],0.4605407693434522
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15822,2219,1.04 [0.93-1.17],0.4471722182723711
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14139,536,1.11 [0.89-1.39],0.3546979371818908
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14195,6931,1.04 [0.97-1.10],0.2512044109114549
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,GI-bleeding,19062,1050,0.96 [0.81-1.14],0.6528054508393508
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18932,43,0.71 [0.26-2.00],0.5230814110245869
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13296,1001,1.01 [0.86-1.20],0.8616954223617659
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18758,58,1.06 [0.52-2.17],0.868322884577629
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Hernia,17841,3048,1.05 [0.96-1.15],0.3042199211826992
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impacted teeth,19541,19,0.89 [0.25-3.18],0.8586055051832923
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impaction of intestines,12523,64,1.07 [0.58-1.97],0.8327702341096435
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,15728,935,1.18 [1.01-1.38],0.0409919587171887
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14892,99,1.28 [0.82-1.98],0.2772572816223898
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12555,96,1.38 [0.94-2.04],0.1027038986815022
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18137,125,1.35 [0.96-1.88],0.0812114533465164
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12888,429,0.84 [0.63-1.12],0.2320793757008163
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19545,271,1.04 [0.74-1.46],0.8096259490516826
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18670,657,1.18 [0.98-1.41],0.0769385795218168
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18925,912,1.16 [0.99-1.35],0.0639976195925342
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13788,185,1.39 [1.04-1.85],0.0237293881077088
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,14190,587,1.18 [0.97-1.43],0.0939548817020565
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19517,114,1.22 [0.81-1.83],0.3515074683738161
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14864,71,1.43 [0.89-2.30],0.1367620727783168
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13620,1161,0.90 [0.76-1.07],0.2357440722184537
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18010,303,1.04 [0.77-1.42],0.7820038977972408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17830,123,1.18 [0.77-1.81],0.4386114343271887
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,14083,1624,0.97 [0.84-1.11],0.616344983795038
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,17636,5177,1.00 [0.93-1.08],0.9248915638190334
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18841,177,1.29 [0.95-1.76],0.1086329308854853
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,19336,636,1.09 [0.89-1.34],0.4148773476764454
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14244,641,1.20 [1.01-1.44],0.0418585152400594
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17886,179,1.35 [0.99-1.84],0.057367895038336
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19431,354,1.05 [0.80-1.38],0.7238692104074165
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14525,922,1.19 [1.02-1.38],0.0286100386097034
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19073,1061,0.95 [0.80-1.13],0.5407301716024707
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19031,142,0.55 [0.29-1.02],0.0578889742945657
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14234,1775,1.07 [0.95-1.20],0.2832802074865237
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15412,1809,1.11 [0.99-1.25],0.0713339542995392
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18792,92,1.24 [0.76-2.01],0.3829199150864595
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18821,808,1.18 [1.00-1.39],0.0450572467823503
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12831,372,1.10 [0.85-1.41],0.4749029337551106
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19536,24,0.77 [0.22-2.77],0.6930259171215136
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,12976,517,1.08 [0.87-1.34],0.4853582151040422
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18151,139,1.09 [0.71-1.67],0.6912293125877806
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19557,44,0.79 [0.49-1.25],0.3103698246341099
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18884,84,0.43 [0.18-1.02],0.0561176389235893
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Toxic colitis,18082,69,1.35 [0.83-2.21],0.2237570429672352
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13895,292,1.32 [1.04-1.69],0.0222510426845511
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,18150,137,1.05 [0.67-1.62],0.8408660053954083
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18123,110,1.06 [0.65-1.73],0.8045045707898407
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,15006,213,0.86 [0.56-1.32],0.493735342156979
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12666,207,0.64 [0.39-1.03],0.0678838022338798
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ventral hernia,15016,223,1.23 [0.89-1.68],0.2101359123829187
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Volvulus,12535,76,0.69 [0.32-1.48],0.3402855030841065
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19480,337,1.21 [0.95-1.53],0.1173243148607479
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19264,61,1.56 [1.03-2.36],0.0347722144692605
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17467,141,1.20 [0.83-1.73],0.3432938995671071
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19044,689,1.11 [0.91-1.35],0.3187365536609244
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18474,119,0.83 [0.47-1.47],0.5166151490249297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17812,486,1.21 [0.97-1.50],0.09245366321074
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19273,261,1.00 [0.71-1.40],0.9857010804774528
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19473,461,1.01 [0.78-1.30],0.9302665097689388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19054,42,1.23 [0.61-2.46],0.5580221940936196
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18211,3087,1.04 [0.95-1.14],0.4197919754572481
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19198,356,1.00 [0.75-1.33],0.9995167823264038
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19088,246,1.05 [0.76-1.46],0.7477287696273631
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19244,889,1.05 [0.88-1.26],0.5832476185317457
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19552,51,0.96 [0.44-2.08],0.9169400537969822
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17380,54,1.33 [0.78-2.28],0.2914108387381355
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18892,50,0.52 [0.18-1.49],0.2210616842869304
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19261,249,0.99 [0.70-1.41],0.9573399873974848
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17825,499,0.88 [0.68-1.15],0.3521535658712816
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17402,76,1.25 [0.76-2.06],0.3715344033308548
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19497,72,0.90 [0.45-1.82],0.7753160222309835
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18531,176,1.15 [0.79-1.68],0.4528915070762667
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19392,189,1.11 [0.77-1.60],0.5877492497240693
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19088,76,0.87 [0.42-1.78],0.696555557768958
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17387,61,0.99 [0.49-1.98],0.9677877793897356
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19050,1724,1.08 [0.95-1.22],0.2345186855810253
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17859,533,0.86 [0.67-1.12],0.2639851047333538
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17405,79,1.25 [0.76-2.04],0.3826114117223445
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19491,288,1.21 [0.93-1.58],0.1541191695053543
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19074,62,0.88 [0.42-1.87],0.7467067173741093
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19439,236,1.27 [0.96-1.68],0.0997975742330341
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19509,366,1.25 [1.00-1.55],0.0500116206399814
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17432,106,1.24 [0.83-1.88],0.2969866635691687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17610,284,0.98 [0.72-1.35],0.9226435749936854
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19497,354,1.25 [1.01-1.56],0.044591583829252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17592,266,1.08 [0.78-1.51],0.6336404744086097
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19544,119,0.93 [0.55-1.58],0.7922090222355711
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16328,68,0.58 [0.24-1.43],0.2378321093906666
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17267,5413,1.05 [0.98-1.12],0.2080662577375176
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16075,4221,1.02 [0.94-1.11],0.5821636552047462
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16306,46,0.46 [0.14-1.46],0.1860452908795193
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16303,116,0.89 [0.52-1.54],0.6823498124474479
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16343,156,1.13 [0.77-1.65],0.5442541798281855
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19356,50,1.37 [0.79-2.39],0.2660708902494919
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16307,120,0.76 [0.42-1.37],0.3634067487341145
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13105,1251,1.07 [0.93-1.23],0.3241318603331788
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19384,211,1.13 [0.81-1.58],0.4608543816506393
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16661,474,1.12 [0.90-1.40],0.3083289078344687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15869,6762,1.06 [1.00-1.13],0.0686011982962789
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17462,102,0.83 [0.46-1.52],0.5507982439189999
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16406,146,0.91 [0.56-1.47],0.6924892461384096
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16687,427,0.93 [0.71-1.22],0.5885898753094546
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18781,2594,1.04 [0.94-1.16],0.4176758487136626
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16528,268,0.86 [0.60-1.23],0.4006855379483669
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16385,125,0.89 [0.53-1.49],0.6450395102183837
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16362,102,0.86 [0.48-1.53],0.607814606023499
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18917,87,0.50 [0.22-1.14],0.0986008405681317
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13537,1683,0.99 [0.86-1.13],0.8783644016563488
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12490,636,1.19 [0.98-1.45],0.0828230640090889
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19484,630,1.15 [0.94-1.41],0.1749874204119434
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11917,63,1.13 [0.65-1.97],0.6613307273318558
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12112,258,1.07 [0.81-1.42],0.6440159280572443
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16480,220,0.90 [0.61-1.33],0.6047270978225396
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12261,407,0.80 [0.58-1.09],0.1530977576806098
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16253,66,1.44 [0.93-2.24],0.1023944563922627
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16748,561,1.07 [0.86-1.33],0.5520031542530526
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16442,255,0.87 [0.60-1.26],0.4631641676451818
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12235,381,0.81 [0.59-1.12],0.20106854022301
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16319,59,0.65 [0.26-1.61],0.3489995808504919
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16307,47,0.98 [0.44-2.17],0.963934124374994
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17426,66,1.23 [0.69-2.19],0.4834257078723981
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19216,1856,1.03 [0.92-1.16],0.5677699665183177
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18673,1313,1.05 [0.91-1.20],0.5145846834747665
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19431,458,1.20 [0.97-1.49],0.0941965990952889
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14482,2628,1.05 [0.95-1.16],0.3604390720487983
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11893,39,1.04 [0.47-2.31],0.9200055577652738
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16342,82,1.14 [0.67-1.92],0.6306134957918157
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11920,66,1.23 [0.70-2.16],0.4645118810696589
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),11967,113,1.00 [0.62-1.62],0.995493531975298
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17559,199,1.18 [0.86-1.63],0.3087599208122571
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17771,411,0.94 [0.71-1.23],0.647485913770408
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19551,91,1.74 [1.32-2.30],8.366582215459967e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17820,1633,1.05 [0.93-1.20],0.4256710085727624
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16319,59,1.39 [0.89-2.18],0.1519938095013546
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),11984,130,0.76 [0.43-1.32],0.3288106448021826
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16838,651,1.00 [0.81-1.24],0.9998341084919092
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13694,1840,1.03 [0.91-1.16],0.6758928665916437
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18936,106,0.65 [0.33-1.28],0.2088113730301758
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19562,59,1.59 [1.06-2.39],0.0235732148025139
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16328,68,0.50 [0.20-1.26],0.1394243313134628
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17382,1122,1.17 [1.02-1.35],0.0260533540097591
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16343,83,0.93 [0.49-1.73],0.8086184146532813
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13606,1752,1.06 [0.93-1.19],0.3854161604088085
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17460,100,0.89 [0.50-1.58],0.691899427311366
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16289,29,1.23 [0.59-2.54],0.5856753002768806
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16348,161,0.99 [0.64-1.53],0.9660830743937772
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16825,565,1.22 [1.01-1.48],0.0380912317539919
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19250,420,1.15 [0.92-1.45],0.2252586395636499
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16723,536,0.93 [0.72-1.19],0.5451960709504019
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19442,452,1.13 [0.89-1.42],0.3105523977191734
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19548,57,1.08 [0.55-2.11],0.8249218309857083
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16396,136,0.91 [0.56-1.49],0.7156723798872909
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15249,733,1.06 [0.87-1.30],0.5521889160880923
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16798,538,1.22 [1.00-1.48],0.0496935798526549
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16502,242,0.90 [0.63-1.31],0.5945909785719705
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11916,62,0.84 [0.39-1.83],0.6632785386869487
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14484,2630,1.10 [1.00-1.21],0.0595243524993248
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12542,688,1.01 [0.83-1.24],0.8970405801267929
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19143,313,0.89 [0.64-1.24],0.5011128677270489
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19522,62,1.76 [1.27-2.44],0.0007240070112897
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17346,57,0.61 [0.23-1.59],0.3096968098010272
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11914,60,1.56 [1.05-2.30],0.0258584678683128
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16280,93,1.02 [0.58-1.77],0.9533193562414116
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12319,465,1.23 [1.01-1.50],0.0442205827587343
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16545,285,1.15 [0.88-1.51],0.3102696269716827
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16427,240,1.41 [1.11-1.80],0.005518298959295
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16404,217,1.02 [0.72-1.46],0.895633376721901
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13789,59,1.53 [1.01-2.32],0.0443065926136366
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19552,61,1.03 [0.53-2.03],0.9215040667578568
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16727,467,1.05 [0.83-1.33],0.6938393854163731
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],18915,85,1.77 [1.34-2.36],7.498268837485985e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18467,2207,1.07 [0.96-1.19],0.2291217922529149
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16384,124,0.83 [0.48-1.44],0.5058160389845694
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16766,579,1.17 [0.96-1.42],0.1118478966831693
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18402,219,0.92 [0.62-1.37],0.6741531634803604
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16387,200,1.18 [0.86-1.63],0.3042582991082363
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17817,1630,1.09 [0.96-1.24],0.1742215176665368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17255,1068,1.13 [0.97-1.31],0.1220516126689106
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16308,48,1.31 [0.74-2.31],0.3553978680242341
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18934,104,1.72 [1.29-2.29],0.000199500049359
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16398,138,0.80 [0.47-1.36],0.4002740031939146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16339,79,0.99 [0.54-1.82],0.978613888418928
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11916,62,1.33 [0.81-2.19],0.2608343690845939
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18453,1785,1.32 [1.19-1.47],1.809596729562644e-07
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7896,23,1.01 [0.34-3.04],0.9863350027624276
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10016,29,1.13 [0.50-2.55],0.7687485868335632
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19297,259,1.05 [0.76-1.45],0.7826936491577817
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19128,90,1.36 [0.87-2.11],0.1777758000204045
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18382,1714,1.27 [1.14-1.42],1.7922597757103336e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19386,88,1.75 [1.30-2.36],0.0002447654142333
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19344,331,1.43 [1.15-1.80],0.0016631693972388
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,16426,244,1.07 [0.77-1.48],0.7029679748765946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Dialysis,16735,67,1.91 [1.37-2.67],0.0001281233916589
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8565,1774,1.05 [0.92-1.19],0.4510724811750368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10097,110,1.12 [0.71-1.77],0.6177800685005688
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Endometriosis,7907,34,1.25 [0.61-2.58],0.5368888742936846
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8358,485,1.06 [0.85-1.33],0.6179343032900566
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16178,5198,1.11 [1.03-1.19],0.0043698263733169
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19366,68,1.54 [0.96-2.50],0.0758856149921697
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydrocele,6893,102,1.08 [0.64-1.82],0.7712866233254234
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16695,274,1.28 [0.98-1.67],0.0666126638517032
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8301,1510,1.08 [0.94-1.23],0.2961285225619759
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10155,133,0.98 [0.61-1.57],0.9390049050000088
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6895,104,0.79 [0.42-1.48],0.4644067786342062
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16251,69,0.72 [0.33-1.61],0.4291856958988851
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8743,870,0.95 [0.78-1.14],0.5646025467532911
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6845,54,1.48 [0.87-2.54],0.1506991041980915
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7905,32,1.08 [0.42-2.76],0.8699304478484683
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19562,71,0.66 [0.29-1.49],0.3157447004136369
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19555,71,1.49 [0.98-2.28],0.0619438912020711
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18575,2393,1.10 [0.99-1.22],0.0649097477663187
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,16968,786,1.11 [0.93-1.33],0.2286016377112771
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10032,45,1.48 [0.88-2.49],0.1436854220527392
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19507,494,1.44 [1.20-1.72],6.532954411626222e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6915,124,0.96 [0.57-1.61],0.8694568881627108
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6922,131,1.02 [0.63-1.67],0.9212141572218292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6916,125,1.19 [0.77-1.84],0.4419461018182659
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19540,69,1.36 [0.86-2.15],0.1903271703564654
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18055,1873,1.16 [1.04-1.30],0.0086588348040467
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10092,70,0.95 [0.49-1.84],0.8835882316967731
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7936,63,1.08 [0.59-1.98],0.809237928563854
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8006,133,0.92 [0.55-1.53],0.7461218357586742
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7922,49,0.56 [0.19-1.62],0.2823225869786219
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7960,87,0.40 [0.17-0.96],0.0406264952454486
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16744,323,1.24 [0.97-1.60],0.0884214368738507
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19171,158,1.40 [1.02-1.92],0.0378698737192484
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7977,104,1.20 [0.78-1.84],0.4175511827381495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7895,22,1.42 [0.71-2.84],0.3152826294741514
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8058,185,1.06 [0.72-1.56],0.7614982369922803
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7955,82,0.84 [0.43-1.63],0.6062099295320524
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8050,177,0.92 [0.59-1.42],0.6900440678582447
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19346,48,1.59 [0.99-2.55],0.0575361710741587
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6920,129,0.97 [0.58-1.62],0.9141694092595
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19364,2943,1.22 [1.11-1.33],1.0077998671732622e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16494,73,1.29 [0.81-2.06],0.2850834762074707
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16806,138,1.14 [0.75-1.73],0.540718565160292
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19069,31,0.86 [0.29-2.52],0.7831996772613604
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16403,221,1.11 [0.79-1.55],0.5441777722760549
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19373,335,1.15 [0.89-1.50],0.2904722674225242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7907,34,0.57 [0.15-2.08],0.3910416260689361
